Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Alfacell (ACEL) -- Ignore unavailable to you. Want to Upgrade?

To: Pluvia who wrote (1461)	7/16/1998 6:55:00 AM
From: Greg Kevorkian	Read Replies (1) \| Respond to of 1533

It looks like all us old timers who have basically be ruined by this are still hanging in. I think we should consolidate the two forums the SI and Yahoo so we can support each other through this and share any significant information. Maybe we can all post to the Yahoo and let the SI fade. Thoughts? A while back their was a scenerio put out about Enzon buying out Alfacell. This was put to management and they denied it. Yesterday Enzon received $17,600,000 and as John stated and I posted on the SI, WHO WAS BUYING. Strange coincidence! Maybe it would be better for them to come in and buy. Thoughts? After listening to the conference call and asked myself, what does Onconase work on. It seemed Stan had no great answer. Thoughts? Why did we have so many stage 4 patients on Onconase and how many stage 4 patients were on the other drugs? Was this apples to apples? Any answers to this? We know there are no drugs out there for Meso, so are we a shue in for approval and hope for "off lable use" or will Doctors not want to use it because it hasn't worked for other things? Will they start the option game all over again? I believe we need to get a shareho;der nominated on the board of directors. This was suggested last year and no support and no communication leading to this. John Jenco would be a perfect choice. Thoughts Greg